What You Should Know:
- New KeyCare survey finds nearly 7 in 10 (68%) of consumers who needed minor but urgent medical services while traveling in the prior year received care via telehealth visits with their regular physicians or affiliated members of their physicians’ care teams, outpacing all other care-delivery options.
- Results are based on a survey of 400 consumers who have previously scheduled and
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Portfolia Invests in Xandar Kardian for Health Monitoring
What You Should Know:
- Portfolia, the world’s most powerful community of women investors, has officially announced a significant investment in Xandar Kardian from the firm’s Active Aging I and Active Aging II funds. Portfolia’s investment represents a core contribution to Xandar Kardian’s $10 million Series A Funding round.
- Portfolia sees Xandar Kardian’s impact extends well beyond the traditional hospital room, with impressive potential growth opportunities into a wider
Read More
Healthy.io & Reset Kidney Health Partner on Comprehensive Virtual Kidney Care
What You Should Know:
- Healthy.io, the global leader in transforming the smartphone camera into a medical device, and Reset Kidney Health, a hybrid care platform that offers gold-standard multidisciplinary care to patients with kidney disease, have announced a partnership that will give patients the option to utilize at-home, smartphone-powered kidney testing.
- As part of the partnership, Reset will provide eligible patients with Healthy.io's Minuteful Kidney™ test to complete at
Read More
What Impact Could AI Have On Genetic Testing?
The sequencing and analysis of human DNA have advanced significantly since the initial draft of a human genome that was published as part of the Human Genome Project. With DNA sequencing becoming increasingly cost-effective, the market for genetic testing is growing at an accelerating rate – the market for Next Generation Sequencing (NGS) services has an estimated annual growth of 18.3% from 2022 to 2030. AI presents a range of possibilities for this rapidly growing field, and in this article,
Read More
ObvioHealth Launches Digital Therapeutics API for Clinical Trials
What You Should Know:
- ObvioHealth launches proprietary application programming interface (API) tailored specifically for digital therapeutics (DTx) clinical trials.
- ObvioHealth’s API ensures tight integration between the digital therapeutic and the ObvioGo platform, providing sponsors with accurate data to correlate efficacy with adherence to the DTx. In addition, ObvioGo’s integration reduces participant task duplication because—in most cases—outcomes can be passively captured
Read More
Eko Launches Cardiac Disease Detection Platform, SENSORA
What You Should Know:
- Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and lung disease launches the SENSORA™ Cardiac Disease Detection Platform.
- SENSORA™ currently features AI that objectively identifies structural murmurs, a sign of valvular heart disease, and Care Pathway Analytics software that provides downstream visibility and metrics of the patient journey through the healthcare system.
Eko SENSORA Cardiac Disease Detection
Read More
Vytalize Health Closes $100M to Support Value-Based Care Transformation
What You Should Know:
- Vytalize Health, a leading risk-bearing provider enablement platform, announced it has closed $100 million in funding led by Enhanced Healthcare Partners and Monroe Capital, with participation from North Coast Ventures.
- Vytalize Health partners with primary care practices for more than 250,000 patients and offers evidence-based recommendations at the point of care. By delivering the right data at the right time in the workflow to physicians and their staff,
Read More
BrightInsight Adds ixlayer to BrightInsight Ecosystem to Improve Therapy Matching
What You Should Know:
- BrightInsight announced that ixlayer has joined the BrightInsight Ecosystem, a network of more than 20 of the world’s leading healthcare and technology companies driving growth and adoption of digital health solutions.
- The BrightInsight Ecosystem of partners collaborates to solve healthcare’s biggest challenges to drive digital innovation, adoption and engagement.
Why It Matters
Conditions such as high cholesterol, autoimmune
Read More
Indegene Launches Metaverse Capabilities for Life Sciences Companies
What You Should Know:
- Indegene, a digital-first, life sciences commercialization company launches metaverse capabilities to support life sciences organizations with a variety of use cases, including health care provider (HCP) interactions, HCP education, and patient education.
- Indegene’s domain expertise will provide life sciences organizations a foundation for navigating the complexity of this emerging technology and the flexibility to create tailored virtual worlds. Using these, life
Read More
Vysioneer & Pfizer Partner on AI-Powered Oncology Clinical Trials
What You Should Know:
- Vysioneer, a provider of applied AI for Oncology, today announced a data-sharing agreement with Pfizer, a global leader in pharmaceuticals. The agreement aims to lay the foundation for the application of AI in oncology clinical trials.
As part of the agreement, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply Vysioneer's advanced machine-learning techniques to facilitate the drug efficacy assessment process, thereby allowing Pfizer
Read More
